Resverlogix Announces Two New Publications on Apabetalone in Kidney Disease Mar 28, 2018 Life Science
Resverlogix Exceeds Full Enrollment for the Pivotal Phase 3 BETonMACE Clinical Trial Mar 19, 2018 Life Science
G1 Therapeutics Unveils Positive Mid-Stage Data for Myelopreservation in SCLC Patients Mar 5, 2018 Life Science
Resverlogix Announces Sixth Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone Feb 26, 2018 Life Science
WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration Feb 23, 2018 Life Science
Wuxi Nextcode Wins Scrip Award for Enabling the Use of The Genome to Make Better Medicine Dec 5, 2017 Life Science
